Cargando…

MUPS Tableting—Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets

Multi-unit pellet system (MUPS) tablets were fabricated by compacting drug-loaded pellets of either crospovidone or microcrystalline cellulose core. These pellets were produced by extrusion-spheronization and coated with ethylcellulose (EC) for a sustained drug release function. Coat damage due to t...

Descripción completa

Detalles Bibliográficos
Autores principales: Thio, Daniel Robin, Heng, Paul Wan Sia, Chan, Lai Wah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785026/
https://www.ncbi.nlm.nih.gov/pubmed/36559308
http://dx.doi.org/10.3390/pharmaceutics14122812
_version_ 1784857953218592768
author Thio, Daniel Robin
Heng, Paul Wan Sia
Chan, Lai Wah
author_facet Thio, Daniel Robin
Heng, Paul Wan Sia
Chan, Lai Wah
author_sort Thio, Daniel Robin
collection PubMed
description Multi-unit pellet system (MUPS) tablets were fabricated by compacting drug-loaded pellets of either crospovidone or microcrystalline cellulose core. These pellets were produced by extrusion-spheronization and coated with ethylcellulose (EC) for a sustained drug release function. Coat damage due to the MUPS tableting process could undermine the sustained release function of the EC-coated pellets. Deformability of the pellet core is a factor that can impact the extent of pellet coat damage. Thus, this study was designed to evaluate the relative performance of drug-loaded pellets prepared with either microcrystalline cellulose (MCC) or crospovidone (XPVP) as a spheronization aid and were comparatively evaluated for their ability to withstand EC pellet coat damage when compacted. These pellets were tableted at various compaction pressures and pellet volume fractions. The extent of pellet coat damage was assessed by the change in drug release after compaction. The findings from this study demonstrated that pellets spheronized with XPVP had slightly less favorable physical properties and experienced comparatively more pellet coat damage than the pellets with MCC. However, MUPS tablets of reasonable quality could successfully be produced from pellets with XPVP, albeit their performance did not match that of vastly mechanically stronger pellets with MCC at higher compaction pressure.
format Online
Article
Text
id pubmed-9785026
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97850262022-12-24 MUPS Tableting—Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets Thio, Daniel Robin Heng, Paul Wan Sia Chan, Lai Wah Pharmaceutics Article Multi-unit pellet system (MUPS) tablets were fabricated by compacting drug-loaded pellets of either crospovidone or microcrystalline cellulose core. These pellets were produced by extrusion-spheronization and coated with ethylcellulose (EC) for a sustained drug release function. Coat damage due to the MUPS tableting process could undermine the sustained release function of the EC-coated pellets. Deformability of the pellet core is a factor that can impact the extent of pellet coat damage. Thus, this study was designed to evaluate the relative performance of drug-loaded pellets prepared with either microcrystalline cellulose (MCC) or crospovidone (XPVP) as a spheronization aid and were comparatively evaluated for their ability to withstand EC pellet coat damage when compacted. These pellets were tableted at various compaction pressures and pellet volume fractions. The extent of pellet coat damage was assessed by the change in drug release after compaction. The findings from this study demonstrated that pellets spheronized with XPVP had slightly less favorable physical properties and experienced comparatively more pellet coat damage than the pellets with MCC. However, MUPS tablets of reasonable quality could successfully be produced from pellets with XPVP, albeit their performance did not match that of vastly mechanically stronger pellets with MCC at higher compaction pressure. MDPI 2022-12-15 /pmc/articles/PMC9785026/ /pubmed/36559308 http://dx.doi.org/10.3390/pharmaceutics14122812 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Thio, Daniel Robin
Heng, Paul Wan Sia
Chan, Lai Wah
MUPS Tableting—Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets
title MUPS Tableting—Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets
title_full MUPS Tableting—Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets
title_fullStr MUPS Tableting—Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets
title_full_unstemmed MUPS Tableting—Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets
title_short MUPS Tableting—Comparison between Crospovidone and Microcrystalline Cellulose Core Pellets
title_sort mups tableting—comparison between crospovidone and microcrystalline cellulose core pellets
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785026/
https://www.ncbi.nlm.nih.gov/pubmed/36559308
http://dx.doi.org/10.3390/pharmaceutics14122812
work_keys_str_mv AT thiodanielrobin mupstabletingcomparisonbetweencrospovidoneandmicrocrystallinecellulosecorepellets
AT hengpaulwansia mupstabletingcomparisonbetweencrospovidoneandmicrocrystallinecellulosecorepellets
AT chanlaiwah mupstabletingcomparisonbetweencrospovidoneandmicrocrystallinecellulosecorepellets